JOINT CORP/THE (JYNT) Stock Fundamental Analysis

NASDAQ:JYNT • US47973J1025

8.68 USD
+0.09 (+1.05%)
At close: Feb 13, 2026
8.71 USD
+0.03 (+0.35%)
After Hours: 2/13/2026, 8:20:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall JYNT gets a fundamental rating of 3 out of 10. We evaluated JYNT against 102 industry peers in the Health Care Providers & Services industry. The financial health of JYNT is average, but there are quite some concerns on its profitability. JYNT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • JYNT had negative earnings in the past year.
  • In the past year JYNT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: JYNT reported negative net income in multiple years.
  • JYNT had a positive operating cash flow in each of the past 5 years.
JYNT Yearly Net Income VS EBIT VS OCF VS FCFJYNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M -15M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -1.40%, JYNT is in line with its industry, outperforming 42.16% of the companies in the same industry.
  • JYNT has a Return On Equity (-4.27%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.4%
ROE -4.27%
ROIC N/A
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
JYNT Yearly ROA, ROE, ROICJYNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

  • JYNT has a Gross Margin of 78.26%. This is amongst the best in the industry. JYNT outperforms 93.14% of its industry peers.
  • JYNT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
JYNT Yearly Profit, Operating, Gross MarginsJYNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • JYNT has more shares outstanding than it did 1 year ago.
  • JYNT has more shares outstanding than it did 5 years ago.
  • JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
JYNT Yearly Shares OutstandingJYNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
JYNT Yearly Total Debt VS Total AssetsJYNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • JYNT has an Altman-Z score of 2.77. This is not the best score and indicates that JYNT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.77, JYNT is doing good in the industry, outperforming 61.76% of the companies in the same industry.
  • There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.77
ROIC/WACCN/A
WACC8.66%
JYNT Yearly LT Debt VS Equity VS FCFJYNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • JYNT has a Current Ratio of 1.83. This is a normal value and indicates that JYNT is financially healthy and should not expect problems in meeting its short term obligations.
  • JYNT has a Current ratio of 1.83. This is in the better half of the industry: JYNT outperforms 72.55% of its industry peers.
  • A Quick Ratio of 1.83 indicates that JYNT should not have too much problems paying its short term obligations.
  • The Quick ratio of JYNT (1.83) is better than 75.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 1.83
JYNT Yearly Current Assets VS Current LiabilitesJYNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 99.03% over the past year.
  • The Revenue for JYNT has decreased by -24.15% in the past year. This is quite bad
  • The Revenue has been growing slightly by 1.36% on average over the past years.
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.54% on average over the next years. This is a very strong growth
  • JYNT is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -22.13% yearly.
EPS Next Y83%
EPS Next 2Y95.15%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue Next Year-54.9%
Revenue Next 2Y-31.56%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JYNT Yearly Revenue VS EstimatesJYNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
JYNT Yearly EPS VS EstimatesJYNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for JYNT. In the last year negative earnings were reported.
  • JYNT is valuated rather expensively with a Price/Forward Earnings ratio of 21.82.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of JYNT is on the same level as its industry peers.
  • JYNT's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.06.
Industry RankSector Rank
PE N/A
Fwd PE 21.82
JYNT Price Earnings VS Forward Price EarningsJYNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -200 -400 -600 -800

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of JYNT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 79.06
EV/EBITDA N/A
JYNT Per share dataJYNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • JYNT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as JYNT's earnings are expected to grow with 44.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y95.15%
EPS Next 3Y44.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • JYNT does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

JOINT CORP/THE

NASDAQ:JYNT (2/13/2026, 8:20:43 PM)

After market: 8.71 +0.03 (+0.35%)

8.68

+0.09 (+1.05%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)03-05
Inst Owners78.47%
Inst Owner Change-86.53%
Ins Owners22.97%
Ins Owner Change2.29%
Market Cap129.07M
Revenue(TTM)91.63M
Net Income(TTM)-970.20K
Analysts76
Price Target10.88 (25.35%)
Short Float %8.53%
Short Ratio10.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.81%
Revenue beat(4)0
Avg Revenue beat(4)-14.21%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)-1.53%
Revenue beat(8)3
Avg Revenue beat(8)-6.24%
Revenue beat(12)3
Avg Revenue beat(12)-4.83%
Revenue beat(16)5
Avg Revenue beat(16)-4.04%
PT rev (1m)-0.77%
PT rev (3m)-28.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-54.29%
EPS NY rev (1m)-12.83%
EPS NY rev (3m)-1366.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.2%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 21.82
P/S 1.41
P/FCF 79.06
P/OCF 42.03
P/B 5.69
P/tB 5.69
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)0.4
Fwd EY4.58%
FCF(TTM)0.11
FCFY1.26%
OCF(TTM)0.21
OCFY2.38%
SpS6.16
BVpS1.53
TBVpS1.53
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.4%
ROE -4.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 78.26%
FCFM 1.78%
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 78.79%
Cap/Sales 1.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.83
Quick Ratio 1.83
Altman-Z 2.77
F-Score6
WACC8.66%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%109.52%
EPS Next Y83%
EPS Next 2Y95.15%
EPS Next 3Y44.54%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.15%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-55.69%
Revenue Next Year-54.9%
Revenue Next 2Y-31.56%
Revenue Next 3Y-22.13%
Revenue Next 5YN/A
EBIT growth 1Y-575.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year312.75%
EBIT Next 3Y60.95%
EBIT Next 5YN/A
FCF growth 1Y-85.24%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-81.35%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%

JOINT CORP/THE / JYNT FAQ

What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to JYNT.


Can you provide the valuation status for JOINT CORP/THE?

ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.


How profitable is JOINT CORP/THE (JYNT) stock?

JOINT CORP/THE (JYNT) has a profitability rating of 3 / 10.


How financially healthy is JOINT CORP/THE?

The financial health rating of JOINT CORP/THE (JYNT) is 6 / 10.